Pluri (PLUR) Other Non-Current Liabilities (2013 - 2025)

Pluri (PLUR) reported Other Non-Current Liabilities of $263000.0 for Q1 2025, down 30.79% quarter-over-quarter from $380000.0 in Q3 2020.

Pluri (PLUR) Other Non-Current Liabilities (2013 - 2025) Analysis & Trends

Pluri (PLUR) has 9 years of Other Non-Current Liabilities data on file, last reported at $263000.0 in Q1 2025.

  • Other Non-Current Liabilities for Q1 2025 came in at $263000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2025 was $263000.0 (changed N/A YoY), and the FY2019 annual result was $381000.0, down 51.03% from the prior year.
  • Other Non-Current Liabilities fell to $263000.0 in Q1 2025 per PLUR's latest filing, from $380000.0 in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $263000.0 in Q1 2025 and troughed at $263000.0 in Q1 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn -
7 Psyence Biomedical 251.43 Bn 251.42 Bn -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn
9 Abivax 94.37 Bn 94.37 Bn -
10 Pluri 21.39 Mn 21.87 Mn 86,000.00

Historic Data

Download Data
DateValue
Mar 31, 2025 263,000.00
Sep 30, 2020 380,000.00
Jun 30, 2019 381,000.00
Mar 31, 2019 705,000.00
Dec 31, 2018 765,000.00
Sep 30, 2018 825,000.00
Jun 30, 2018 778,000.00
Mar 31, 2018 838,000.00
Dec 31, 2017 897,000.00
Sep 30, 2017 869,000.00
Jun 30, 2017 929,000.00
Mar 31, 2017 920,000.00
Dec 31, 2016 980,000.00
Sep 30, 2016 1.04 Mn
Jun 30, 2016 1.10 Mn
Dec 31, 2015 1.22 Mn
Sep 30, 2015 481,000.00
Jun 30, 2015 502,000.00
Dec 31, 2014 544,000.00
Sep 30, 2014 566,000.00